WSNAF
Wesana Health Holdings Inc.
OTC Markets OTCPKUSDEQUITY
DELAYED
Last price
0.00
■ 0.00 (0.00%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
—
Prev close
0.00
Day high
0.02
Day low
0.01
Volume
15.92K
Market cap
—
P/E (TTM)
—
52W range
0.00 – 0.04
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
0.00%
+1.4%
1M
0.00%
-3.7%
3M
-78.53%
-81.6%
6M
-78.53%
-89.6%
YTD
-65.00%
-77.3%
1Y
-79.71%
-99.7%
3Y
-87.50%
-161.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | — |
| Cost of revenue | — | — | $185.65K | — |
| Gross profit | — | — | $81.56K | — |
| Research & development | — | — | $3.01M | — |
| Selling, general & admin | $1.10M | $3.28M | $4.68M | -66.3% |
| Total operating expense | $1.10M | $3.28M | $4.68M | -66.3% |
| Operating income | -$1.10M | -$3.28M | -$4.68M | +66.3% |
| Net interest income | $16.39K | -$18.50K | -$19.03K | +188.6% |
| Pre-tax income | -$2.03M | -$3.17M | -$6.34M | +36.0% |
| Tax provision | — | — | $0 | — |
| Net income | -$1.72M | -$8.60M | -$34.34M | +80.0% |
| Net income to common | -$1.72M | -$8.60M | -$34.34M | +80.0% |
| Basic EPS | -0.05 | -0.25 | -1.48 | +80.0% |
| Diluted EPS | -0.05 | -0.25 | -1.48 | +80.0% |
| EBIT | -$2.02M | -$3.09M | -$6.32M | +34.7% |
| EBITDA | -$2.02M | -$3.09M | -$6.32M | +34.7% |
| Basic shares | 35.04M | 34.38M | 23.15M | +1.9% |
| Diluted shares | 35.04M | 34.38M | 23.15M | +1.9% |
| Line item | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $42.72K | $446.39K | $6.58M | -90.4% |
| Cash & short-term investments | $269.67K | $450.59K | $6.59M | -40.2% |
| Accounts receivable | — | $0 | $8.46K | — |
| Total current assets | $623.05K | $1.93M | $7.42M | -67.8% |
| Property, plant & equipment | — | $0 | $516.56K | — |
| Goodwill & intangibles | — | $0 | $1.78M | — |
| Total assets | $993.05K | $1.93M | $9.74M | -48.7% |
| Total current liabilities | $1.27M | $969.07K | $1.43M | +30.6% |
| Current debt | $250.00K | $295.13K | $157.30K | -15.3% |
| Total debt | $250.00K | $295.13K | $645.13K | -15.3% |
| Total liabilities | $1.27M | $969.07K | $2.03M | +30.6% |
| Retained earnings | -$42.20M | -$43.03M | -$34.43M | +1.9% |
| Shareholder equity | -$272.62K | $965.11K | $7.71M | -128.2% |
| Working capital | -$642.62K | $965.11K | $5.99M | -166.6% |
| Net tangible assets | -$272.62K | $965.11K | $5.94M | -128.2% |
| Shares issued | 20.63M | 20.63M | 19.08M | 0.0% |
| Line item | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|
| Net income | -$2.03M | -$3.17M | -$6.31M | +36.0% |
| Depreciation & amortisation | — | — | $53.33K | — |
| Stock-based compensation | $454.74K | $1.13M | $2.34M | -59.6% |
| Change in working capital | $625.45K | $554.51K | -$312.02K | +12.8% |
| Operating cash flow | -$865.31K | -$7.69M | -$11.99M | +88.7% |
| Capital expenditure | — | — | -$20.07K | — |
| Investing cash flow | $494.89K | $512.13K | $2.42M | -3.4% |
| Financing cash flow | -$63.95K | $1.15M | $14.92M | -105.6% |
| Free cash flow | -$865.31K | -$7.69M | -$11.99M | +88.7% |
| End cash position | $42.72K | $446.39K | $6.58M | -90.4% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.00
-0.00% from price
SMA 20
0.00
0.00% from price
SMA 50
0.01
-60.57% from price
SMA 100
0.01
-72.20% from price
SMA 200
0.01
-72.75% from price
EMA 12
0.00
-2.80% from price
EMA 26
0.00
-28.19% from price
EMA 50
0.01
-53.30% from price
RSI (14)
0.1
Oversold
MACD (12,26,9)
-0.00
Hist 0.00
ATR (14)
0.00
—
Realised vol 30D
438.4%
Annualised
Bollinger upper
0.00
20, 2σ
Bollinger lower
0.00
20, 2σ
50 / 200 cross
Death
0.01 vs 0.01
Trend bias
Below 200
-72.75%
Risk profile
Beta vs SPY
1.95
More volatile than market
Correlation to SPY
0.05
Largely independent
Realised vol 30D
438.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-87.8%
Peak to trough
Max drawdown 5Y
-99.9%
Peak to trough
ATR 14
0.00
Average true range
Beta (reported)
—
5Y monthly, from filing
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.